ARCHIVES

DCT Board Oks Recompetition Of Master Agreement For BRM Trials

This article is from The Cancer Letter archive.

Vol. 09 No. 05 | February 4, 1983

Download PDF Visit The Full Archive

Related Articles

Palbocicilib Doubles PFS In Phase II Trial to 20.2 Months

April 25, 2014

Strategic Plan Identifies Goal; To Be The Authoritative Source For Cancer Information

May 21, 1999

New HIP Analysis Supports Mammography Screening Ages 40-49

September 23, 1988

ECOG Subcontractors Critique Cancer Control Program

August 24, 1979

Study: Vismodegib Effective Where Surgery is Inappropriate

June 24, 2011

In Brief: NCAB Vacancies Remained Unfilled; AHF’s 20thAnniversary To Be Celebrated In NY May 24

May 5, 1989